Deputy Director, Office of Cardiovascular DevicesU.S. Food and Drug AdministrationSilver Spring, Maryland, United States
Disclosure information not submitted.
CRT 2024 | Faculty Assignment [FDA]
Saturday, March 9, 20249:00 AM – 9:00 PM ET